logo

For the Inventor, By the Inventor

Yotsukaido, Japan

Kotaro Nakayama

This inventor holds 10 USPTO granted patents and 2 published patent applications. Top assignee: Toyo Suisan Kaisha, Ltd.. Active years: 2002-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kotaro Nakayama. Retrieved from https://idiyas.com/inventor/kotaro-nakayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 40.0

Average Co-Inventor Count = 7.5

ph-index = 4

Forward Citations = 26(Granted Patents)


Company Filing History:

goldMedal10 out of 25 
 
Toyo Suisan Kaisha, Ltd.
 patents

Years Active: 2002-2008

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7378398 - Method for treating cancer (2008-05-27),
2. 7148200 - Method for treating cancer (2006-12-12),
3. 6770629 - Administration of a sulfopyranosylacylglycerol to treat certain cancers (2004-08-03),
4. 6759522 - Sulforhamnosylacyglycerol derivatives and use thereof as medicaments (2004-07-06),
5. 6740640 - Sulfofucosylacylglycerol derivatives and administration thereof as medicaments (2004-05-25),
6. 6670361 - Method of treating cancer (2003-12-30),
7. 6518410 - Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments (2003-02-11),
8. 6518248 - Method of treating gastric or colon cancer by administration of a sulfoquinovosylacylglycerol ester (2003-02-11),
9. 6444795 - 1-0-(2-propenyl)-6-0-sulfonylpyranosides (2002-09-03),
10. 6395886 - 1-O-(2-propenyl)-6-deoxy-6-carbonylthiopyranosides (2002-05-28),

Title: Kotaro Nakayama: Innovator in Cancer Treatment

Introduction: Kotaro Nakayama, a pioneering inventor based in Yotsukaido, Japan, has made significant contributions to the field of cancer treatment. With a robust portfolio of 10 patents, Nakayama's work demonstrates his commitment to developing groundbreaking methods for addressing various types of cancer.

Latest Patents: Among Nakayama's latest innovations are two patents focused on novel methods for treating cancer. The first patent describes a method for treating adenocarcinoma, which excludes colon, lung, and gastric cancers. This method involves the administration of a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound, which is represented by a specific chemical formula. The second patent offers a method for treating cancers classified as epithelioma, glioma, sarcoma, melanoma, lymphoma, and leukemia, as well as adenocarcinomas excluding certain types. Similar to the first, this method also utilizes a sulfoquinovosylacylglycerol compound to provide effective treatment.

Career Highlights: Nakayama's career is marked by his association with Toyo Suisan Kaisha, Ltd., where he has dedicated his efforts to research and development in oncology. His innovative spirit has led to advancements in healthcare, particularly in the treatment of challenging cancer types, further solidifying his status as an influential figure in the industry.

Collaborations: Throughout his career, Nakayama has collaborated with several distinguished colleagues, including Takayuki Yamazaki and Fumio Sugawara. These partnerships have fostered a creative environment for innovation, enabling the development of impactful solutions to complex medical problems.

Conclusion: With his impressive track record and significant contributions to cancer treatment, Kotaro Nakayama stands as a testament to the power of innovation in medicine. His patents not only reflect his expertise but also offer hope for better treatment options for cancer patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…